S100A4 blockage alleviates agonistic anti-CD137 antibody-induced liver pathology without disruption of antitumor immunity

DOI: 10.1080/2162402X.2017.1296996

Keywords: cancer immunotherapy, CD137, CD8+ T cell, liver pathology, S100A4

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text